STOCK TITAN

Yunhong Green CTI flags going-concern doubt in Q3

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Yunhong Green CTI Ltd. (YHGJ) reported third-quarter 2026 net sales of $3.127 million, up 6% from $2.953 million a year earlier, and net loss of $866,000 compared with $811,000. For the first nine months, sales were $13.180 million versus $13.212 million, and net loss was $1.750 million versus $1.412 million. Operating cash flow was $2.240 million.

At September 30, 2026, cash was $111,000; $4.8 million was outstanding on the revolving facility, with $2.2 million available. Management says cash and expected operating cash are insufficient for anticipated operating needs over the next 12 months without additional financing, and disclosed substantial doubt about continuing as a going concern. Plans include additional capital, potentially through a registered equity offering, and borrowings. The senior facilities mature April 30, 2027.

YHGJ concluded its disclosure controls and internal control over financial reporting were ineffective as of September 30, 2026, due to material weaknesses; planned remediation includes outside accounting support and enhanced management review. Two customers represented 55% and 29% of third-quarter sales, and their receivables were 99% of gross accounts receivable.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

2 major · 4 points

How the balance works

Positive

  • Moderate pointThird-quarter net sales increased 6% to $3.127 million.

Negative

  • Major pointManagement disclosed substantial doubt about one-year going-concern continuity.
  • Major pointMaterial weaknesses left controls ineffective as of September 30, 2026.
  • Moderate pointNine-month net loss rose to $1.750 million from $1.412 million.
  • Moderate pointTwo customers represented 55% and 29% of third-quarter sales.

Filing Explained

At September 30, 2026, 903,172 common shares were reserved for preferred conversion; the warrants now expire in March 2029.

Under agreements dated September 29, 2026, two preferred holders cannot convert their Series E or F shares, exercise related warrants, or transfer those securities during a restricted period; after it ends, conversions or exercises can add common shares and reduce existing holders’ ownership percentages.

The restriction ends 61 days after a holder gives termination notice, which cannot be given before the later of the proposed offering’s closing or abandonment and the agreement’s second anniversary.

The preferred conversion price is the lower of a fixed price and the lowest daily VWAP in the preceding ten trading days, with no stated minimum; 903,172 common shares were reserved for conversion at September 30, 2026, and the reserve can vary with the market price. The related warrants cover 55,600 shares; their expiration was extended from March 11, 2027 to March 11, 2029 without changing the share count or exercise-price terms.

Separately, the August 24, 2026 credit amendment raised the seasonal overadvance limit from $250,000 to $300,000; the limit expires December 31, 2026, and any outstanding overadvance must be repaid by January 31, 2027.

Third-quarter net sales $3.127 million Three months ended September 30, 2026; up 6% from $2.953 million in the comparable 2025 period.
Third-quarter net loss $866,000 Three months ended September 30, 2026, compared with $811,000 in the comparable 2025 period.
Nine-month net sales $13.180 million Nine months ended September 30, 2026, compared with $13.212 million in the comparable 2025 period.
Nine-month net loss $1.750 million Nine months ended September 30, 2026, compared with $1.412 million in the comparable 2025 period.
Cash and cash equivalents $111,000 As of September 30, 2026.
Revolving facility balance $4.8 million As of September 30, 2026.
Remaining revolving borrowing capacity $2.2 million As of September 30, 2026.
Going-concern assessment Substantial doubt for one year from issuance Management's assessment.
going concern financial
"substantial doubt about the ability of the Company to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
borrowing base financial
"subject to borrowing base provisions"
A borrowing base is the amount a lender will allow a company to borrow based on the value of assets the company offers as security, typically things like accounts receivable and inventory. It matters to investors because it sets a practical ceiling on short-term financing and influences a company’s liquidity and risk: if the borrowing base falls, the company may lose access to cash or be forced to sell assets, which can affect operations and share value.
seasonal overadvance limit financial
"increase the seasonal overadvance limit from $250,000 to $300,000"
volume-weighted average price financial
"lowest daily volume-weighted average price of the common stock"
Volume-weighted average price (VWAP) is the average price of a stock over a specific time period where each trade is weighted by the number of shares traded, so larger trades influence the average more than small ones. Investors and traders use VWAP as a reference point to judge whether trades are happening at relatively good or poor prices—like checking the average price paid for an item at a market where bulk purchases count more than single-item buys.
material weakness regulatory
"identified the following material weaknesses in our internal control over financial reporting"
A material weakness is a significant flaw in the systems and checks a company uses to ensure its financial reports are accurate, meaning errors or fraud could happen and not be caught. For investors it matters because it raises the risk that reported results are unreliable—similar to finding a hole in a ship’s hull—potentially leading to corrected financials, regulatory action, reduced trust, and negative effects on stock value and borrowing costs.
liquidation preference financial
"have a liquidation preference over common stock"
A liquidation preference is a rule that determines who gets paid first and how much they receive when a company is sold, goes bankrupt, or distributes its assets. It gives certain investors a priority claim—often returning their original investment plus any agreed multiple—before other owners receive money, which shapes how much common shareholders and founders ultimately get; think of it as a front-of-the-line pass that affects payout order and investor returns.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were YHGJ's sales and net loss for the third quarter of 2026?

Net sales were $3.127 million and net loss was $866,000 for the three months ended September 30, 2026. The comparable 2025 figures were $2.953 million and $811,000, respectively; sales increased 6%.

Why did YHGJ disclose substantial doubt about its ability to continue as a going concern?

Management said existing cash and cash expected from operations are not expected to fund anticipated operating requirements over the next 12 months without additional financing. Its plans include raising capital, potentially through a registered equity offering, and borrowings; the senior facilities mature April 30, 2027.

What changed under YHGJ's August 2026 credit amendment?

The amendment increased the seasonal overadvance limit from $250,000 to $300,000, effective August 28, 2026, and required a one-time $20,000 payment. The limit expires December 31, 2026, and outstanding overadvance amounts must be repaid by January 31, 2027.

What controls did YHGJ say were ineffective?

Management concluded that disclosure controls and internal control over financial reporting were ineffective as of September 30, 2026, due to material weaknesses. Planned remediation includes outside technical accounting support, enhanced management review, and periodic reporting to the Audit Committee.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --12-31 Q3 0001042187 0001042187 2026-01-01 2026-09-30 0001042187 2026-11-13 0001042187 2026-09-30 0001042187 2025-12-31 0001042187 us-gaap:NonrelatedPartyMember 2026-09-30 0001042187 us-gaap:NonrelatedPartyMember 2025-12-31 0001042187 us-gaap:RelatedPartyMember 2026-09-30 0001042187 us-gaap:RelatedPartyMember 2025-12-31 0001042187 us-gaap:SeriesEPreferredStockMember 2026-09-30 0001042187 us-gaap:SeriesEPreferredStockMember 2025-12-31 0001042187 us-gaap:SeriesFPreferredStockMember 2026-09-30 0001042187 us-gaap:SeriesFPreferredStockMember 2025-12-31 0001042187 2025-10-01 2025-10-01 0001042187 2026-07-01 2026-09-30 0001042187 2025-07-01 2025-09-30 0001042187 2025-01-01 2025-09-30 0001042187 2024-12-31 0001042187 2025-09-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001042187 us-gaap:CommonStockMember 2025-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001042187 us-gaap:RetainedEarningsMember 2025-12-31 0001042187 us-gaap:TreasuryStockCommonMember 2025-12-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001042187 us-gaap:CommonStockMember 2026-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001042187 us-gaap:RetainedEarningsMember 2026-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2026-03-31 0001042187 2026-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001042187 us-gaap:CommonStockMember 2026-06-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001042187 us-gaap:RetainedEarningsMember 2026-06-30 0001042187 us-gaap:TreasuryStockCommonMember 2026-06-30 0001042187 2026-06-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001042187 us-gaap:CommonStockMember 2024-12-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001042187 us-gaap:RetainedEarningsMember 2024-12-31 0001042187 us-gaap:TreasuryStockCommonMember 2024-12-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001042187 us-gaap:CommonStockMember 2025-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001042187 us-gaap:RetainedEarningsMember 2025-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2025-03-31 0001042187 2025-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001042187 us-gaap:CommonStockMember 2025-06-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001042187 us-gaap:RetainedEarningsMember 2025-06-30 0001042187 us-gaap:TreasuryStockCommonMember 2025-06-30 0001042187 2025-06-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001042187 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0001042187 2026-01-01 2026-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001042187 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001042187 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001042187 us-gaap:TreasuryStockCommonMember 2026-04-01 2026-06-30 0001042187 2026-04-01 2026-06-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0001042187 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001042187 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001042187 us-gaap:TreasuryStockCommonMember 2026-07-01 2026-09-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001042187 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001042187 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001042187 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001042187 2025-01-01 2025-03-31 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001042187 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001042187 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001042187 us-gaap:TreasuryStockCommonMember 2025-04-01 2025-06-30 0001042187 2025-04-01 2025-06-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001042187 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001042187 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001042187 us-gaap:TreasuryStockCommonMember 2025-07-01 2025-09-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2026-09-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2026-09-30 0001042187 us-gaap:CommonStockMember 2026-09-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001042187 us-gaap:RetainedEarningsMember 2026-09-30 0001042187 us-gaap:TreasuryStockCommonMember 2026-09-30 0001042187 us-gaap:SeriesEPreferredStockMember us-gaap:PreferredStockMember 2025-09-30 0001042187 us-gaap:SeriesFPreferredStockMember us-gaap:PreferredStockMember 2025-09-30 0001042187 us-gaap:CommonStockMember 2025-09-30 0001042187 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001042187 us-gaap:RetainedEarningsMember 2025-09-30 0001042187 us-gaap:TreasuryStockCommonMember 2025-09-30 0001042187 us-gaap:RevolvingCreditFacilityMember YHGJ:NewCreditAgreementsMember 2025-09-30 0001042187 YHGJ:NewCreditAgreementsMember YHGJ:TermLoanMember 2025-09-30 0001042187 us-gaap:RevolvingCreditFacilityMember YHGJ:LineFinancialAgreementMember 2021-09-30 0001042187 YHGJ:TermLoanMember YHGJ:LineFinancialAgreementMember 2021-09-30 0001042187 YHGJ:LineFinancialAgreementMember us-gaap:RevolvingCreditFacilityMember 2026-09-30 0001042187 YHGJ:LineFinancialAgreementMember YHGJ:TermLoanMember 2026-09-30 0001042187 YHGJ:LineFinancialAgreementMember 2021-09-30 2021-09-30 0001042187 YHGJ:LineFinancialAgreementMember 2025-09-30 2025-09-30 0001042187 YHGJ:LineFinancialAgreementMember us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2025-09-30 0001042187 YHGJ:LineFinancialAgreementMember us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2025-09-30 0001042187 YHGJ:LineFinancialAgreementMember us-gaap:RevolvingCreditFacilityMember 2025-09-30 0001042187 YHGJ:LineFinancialAgreementMember us-gaap:RevolvingCreditFacilityMember 2026-08-23 0001042187 YHGJ:LineFinancialAgreementMember us-gaap:RevolvingCreditFacilityMember 2026-08-24 0001042187 YHGJ:LineFinancialAgreementMember 2026-08-24 2026-08-24 0001042187 YHGJ:LineFinancialAgreementMember 2023-09-29 2023-09-30 0001042187 YHGJ:LineFinancialAgreementMember YHGJ:TermLoanMember 2025-12-31 0001042187 us-gaap:RevolvingCreditFacilityMember YHGJ:LineFinancialAgreementMember 2025-12-31 0001042187 YHGJ:JohnHSchwanMember 2023-12-31 0001042187 YHGJ:JohnHSchwanMember 2024-01-01 2024-01-31 0001042187 YHGJ:JohnHSchwanMember 2026-09-30 0001042187 us-gaap:SeriesEPreferredStockMember 2026-01-01 2026-09-30 0001042187 us-gaap:SeriesFPreferredStockMember 2026-01-01 2026-09-30 0001042187 us-gaap:WarrantMember 2026-09-30 0001042187 us-gaap:SeriesEPreferredStockMember 2026-09-29 2026-09-29 0001042187 srt:MinimumMember 2026-09-30 0001042187 us-gaap:WarrantMember 2025-12-31 0001042187 us-gaap:WarrantMember 2026-01-01 2026-09-30 0001042187 YHGJ:TwoThousandAndTwentyFiveCommonStockWarrantsMember 2026-09-30 0001042187 us-gaap:PreferredStockMember 2026-09-30 0001042187 YHGJ:RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember 2025-12-31 0001042187 YHGJ:RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember 2026-01-01 2026-09-30 0001042187 YHGJ:RestrictedStockUnitsPerformanceBasedRestrictedStockUnitsAndRestrictedStockAwardsMember 2026-09-30 0001042187 YHGJ:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001042187 YHGJ:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001042187 YHGJ:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-07-01 2026-09-30 0001042187 YHGJ:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-07-01 2025-09-30 0001042187 YHGJ:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001042187 YHGJ:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001042187 YHGJ:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2026-01-01 2026-09-30 0001042187 YHGJ:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-09-30 0001042187 YHGJ:TwoCustomersMember 2026-09-30 0001042187 YHGJ:JohnHSchwanMember 2025-12-31 0001042187 YHGJ:IcyMelonLLCMember 2025-01-13 2025-01-13 0001042187 YHGJ:IcyMelonLLCMember 2026-07-01 2026-09-30 0001042187 YHGJ:IcyMelonLLCMember 2025-07-01 2025-09-30 0001042187 YHGJ:IcyMelonLLCMember 2026-09-30 0001042187 YHGJ:IcyMelonLLCMember 2025-12-31 0001042187 YHGJ:IcyMelonLLCMember 2026-01-01 2026-09-30 0001042187 YHGJ:IcyMelonLLCMember 2025-01-01 2025-12-31 0001042187 srt:MaximumMember 2026-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure YHGJ:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 10-Q

 

(Mark One)

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________to__________

 

Commission File Number

000-23115

 

YUNHONG GREEN CTI LTD.

(Exact name of registrant as specified in its charter)

 

Illinois   36-2848943
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

22160 N. Pepper Road    
Barrington, Illinois   60010
(Address of principal executive offices)   (Zip Code)

 

(847) 382-1000

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, no par value per share   YHGJ   The Nasdaq Stock Market LLC
        (The Nasdaq Capital Market)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

The number of shares outstanding of the registrant’s common stock, no par value per share, as of November 13, 2026 was 2,609,244 (excluding treasury shares).

 

 

 

 
 

 

INDEX

 

PART I – FINANCIAL INFORMATION  
     
Item No. 1. Financial Statements  
  Unaudited Condensed Consolidated Balance Sheets at September 30, 2026 and December 31, 2025 1
  Unaudited Condensed Consolidated Statements of Income (Loss) for the three and nine months ended September 30, 2026 and 2025 2
  Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2026 and 2025 3
  Unaudited Condensed Consolidated Statements of Shareholders’ Equity for the three and nine months ended September 30, 2026 and 2025 4
  Notes to Unaudited Condensed Consolidated Financial Statements 5
Item No. 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 11
Item No. 3 Quantitative and Qualitative Disclosures Regarding Market Risk 15
Item No. 4 Controls and Procedures 15
     
PART II – OTHER INFORMATION  
     
Item No. 1 Legal Proceedings 17
Item No. 1A Risk Factors 17
Item No. 2 Unregistered Sales of Equity Securities and Use of Proceeds 17
Item No. 3 Defaults Upon Senior Securities 17
Item No. 4 Mine Safety Disclosures 17
Item No. 5 Other Information 17
Item No. 6 Exhibits 18
  Signatures 19
  Exhibit 31.1  
  Exhibit 31.2  
  Exhibit 32  

 

 
Table of Contents

 

Yunhong Green CTI, Ltd.

Unaudited Condensed Consolidated Balance Sheets

 

   September 30,   December 31, 
   2026   2025 
ASSETS          
Current assets:          
Cash and cash equivalents  $111,000   $97,000 
Accounts receivable, net   3,077,000    5,955,000 
Inventories   8,140,000    8,738,000 
Prepaid expenses   235,000    283,000 
Deferred offering costs   27,000    - 
           
Total current assets   11,590,000    15,073,000 
           
Property, plant and equipment:          
Machinery and equipment   22,161,000    21,993,000 
Office furniture and equipment   2,122,000    2,122,000 
Intellectual property   783,000    783,000 
Leasehold improvements   39,000    39,000 
Fixtures and equipment   518,000    518,000 
Projects under construction   78,000    140,000 
Property, plant and equipment gross   25,701,000    25,595,000 
Less: accumulated depreciation and amortization   (22,023,000)   (21,599,000)
           
Total property, plant and equipment, net   3,678,000    3,996,000 
           
Other assets:          
Operating lease right-of-use   2,926,000    3,393,000 
           
Total other assets   2,926,000    3,393,000 
           
TOTAL ASSETS  $18,194,000   $22,462,000 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current liabilities:          
Trade payables  $1,819,000   $1,677,000 
Line of credit   4,804,000    6,822,000 
Notes payable – current portion   415,000    146,000 
Notes payable related party   344,000    344,000 
Operating lease liabilities – current portion   692,000    596,000 
Advance investor deposits   225,000    150,000 
Accrued liabilities   664,000    950,000 
           
Total current liabilities   8,963,000    10,685,000 
           
Long-term liabilities:          
Notes payable – net of current portion   -    348,000 
Operating lease liabilities – noncurrent   2,340,000    2,873,000 
           
Total long-term liabilities   2,340,000    3,221,000 
           
TOTAL LIABILITIES  $11,303,000   $13,906,000 
           
SHAREHOLDERS’ EQUITY          
Series E Preferred Stock — no par value, 130,000 shares authorized, issued and outstanding at September 30, 2026 and December 31, 2025 (liquidation preference of $1,300,000)   1,060,000    976,000 
Series F Preferred Stock — no par value, 70,000 shares authorized, issued and outstanding at September 30, 2026 and December 31, 2025 (liquidation preference of $700,000)   570,000    525,000 
Common stock - no par value, 2,000,000,000 shares authorized, 2,613,670 and 2,601,788 shares issued and 2,609,244 and 2,597,362 shares outstanding at September 30, 2026 and December 31, 2025, respectively   27,891,000    27,891,000 
Additional paid-in-capital   7,667,000    7,711,000 
Accumulated deficit   (30,136,000)   (28,386,000)
Less: Treasury stock, 4,426 shares, at cost   (161,000)   (161,000)
           
TOTAL SHAREHOLDERS’ EQUITY   6,891,000    8,556,000 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $18,194,000   $22,462,000 

 

See accompanying notes to unaudited condensed consolidated financial statements.

Reflects a 1-for-10 reverse stock split of the Company’s common stock, effective October 1, 2025

 

1
Table of Contents

 

Yunhong Green CTI, Ltd.

Unaudited Condensed Consolidated Statements of Income (Loss)

 

   2026   2025   2026   2025 
   For the Three Months Ended   For the Nine Months Ended 
   September 30,   September 30, 
   2026   2025   2026   2025 
                 
Net sales  $3,127,000   $2,953,000   $13,180,000   $13,212,000 
                     
Cost of sales   2,796,000    2,886,000    11,296,000    11,301,000 
                     
Gross profit   331,000    67,000    1,884,000    1,911,000 
                     
Operating expenses:                    
General and administrative   868,000    869,000    2,466,000    2,462,000 
Selling   36,000    37,000    107,000    109,000 
Advertising and marketing   117,000    144,000    418,000    482,000 
                     
Total operating expenses   1,021,000    1,050,000    2,991,000    3,053,000 
                     
Loss from operations   (690,000)   (983,000)   (1,107,000)   (1,142,000)
                     
Other (expense) income:                    
Interest expense   (183,000)   (198,000)   (651,000)   (662,000)
Other income/(expense)   7,000    370,000    8,000    392,000 
                     
Total other expense (income), net   (176,000)   172,000    (643,000)   (270,000)
                     
Net loss   (866,000)   (811,000)   (1,750,000)   (1,412,000)
                     
Deemed dividends on preferred stock  $(43,000)  $(43,000)  $(129,000)  $(128,000)
                     
Net loss attributable to common shareholders  $(909,000)  $(854,000)  $(1,879,000)  $(1,540,000)
                     
Basic income (loss) per common share  $(0.35)  $(0.31)  $(0.72)  $(0.58)
Diluted income (loss) per common share  $(0.35)  $(0.31)  $(0.72)  $(0.58)
                     
Weighted average number of shares and equivalent shares of common stock outstanding:                    
Basic   2,609,244    2,733,863    2,606,335    2,653,638 
                     
Diluted   2,609,244    2,733,863    2,606,335    2,653,638 

 

See accompanying notes to unaudited condensed consolidated financial statements.

Reflects a 1-for-10 reverse stock split of the Company’s common stock, effective October 1, 2025

 

2
Table of Contents

 

Yunhong Green CTI, Ltd.

Unaudited Condensed Consolidated Statements of Cash Flows

 

   2026   2025 
   For the Nine Months Ended September 30, 
   2026   2025 
         
Cash flows from operating activities:          
Net loss  $(1,750,000)  $(1,412,000)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:          
Depreciation and amortization   424,000    478,000 
Equity compensation charge   58,000    18,000 
           
Change in assets and liabilities:          
Accounts receivable   2,878,000    2,712,000 
Inventories   598,000    (187,000)
Prepaid expenses and other assets   71,000    228,000 
Trade payables   142,000    212,000 
Operating leases   30,000    57,000 
Advance investor deposit   75,000    100,000 
Accrued liabilities   (286,000)   94,000 
           
Net cash provided by (used in) operating activities   2,240,000    2,300,000 
           
Cash flows from investing activities:          
Purchases of property, plant and equipment   (106,000)   (68,000)
           
Net cash provided by (used in) investing activities   (106,000)   (68,000)
           
Cash flows from financing activities:          
Payment of financing costs   (23,000)   - 
Repayment of note payable   (79,000)   (66,000)
Net repayments on revolving line of credit   (2,018,000)   (1,999,000)
           
Net cash provided by (used in) financing activities   (2,120,000)   (2,065,000)
           
Net increase (decrease) in cash and cash equivalents   14,000    167,000 
           
Cash and cash equivalents at beginning of period   97,000    220,000 
           
Cash and cash equivalents at end of period  $111,000   $387,000 
           
Supplemental disclosure of cash flow information and noncash investing and financing activities:          
Cash payments for interest  $651,000   $662,000 
Accretion of dividends on preferred stock   129,000    129,000 
Incremental fair value upon modification of common stock warrants  $27,000    - 
Conversion of advance received from investors into common stock        1,050,000 
Common stock issued in exchange for rent due to Icy Mellon   -    182,000 

 

See accompanying notes to unaudited condensed consolidated financial statements.

Reflects a 1-for-10 reverse stock split of the Company’s common stock, effective October 1, 2025

 

3
Table of Contents

 

Yunhong Green CTI, Ltd

Unaudited Condensed Consolidated Statements of Shareholders’ Equity

 

   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Earnings   Shares   Amount   TOTAL 
   Series E Preferred Stock   Series F Preferred Stock   Common Stock   Paid-in   Accumulated (Deficit)  

Less

Treasury Stock

     
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Earnings   Shares   Amount   TOTAL 
                                             
Balance December 31, 2025   130,000   $976,000    70,000   $525,000    2,601,788   $27,891,000   $7,711,000   $(28,386,000)   (4,426)  $(161,000)  $8,556,000 
                                                        
Series E Accrued Deemed Dividend   -    28,000    -    -    -    -    (28,000)   -    -    -    - 
Series F Accrued Deemed Dividend   -    -    -    15,000    -    -    (15,000)   -    -    -    - 
Stock Issuance - Vesting Milestone   -    -    -    -    6,917    -    38,000    -    -    -    38,000 
Equity Compensation Charge   -    -    -    -    -    -    6,000    -    -    -    6,000 
Net Loss   -    -    -    -    -    -    -    (341,000)   -    -    (341,000)
                                                        
Balance March 31, 2026   130,000   $1,004,000    70,000   $540,000    2,608,705   $27,891,000   $7,712,000   $(28,727,000)   (4,426)  $(161,000)  $8,259,000 
                                                        
Series E Accrued Deemed Dividend   -    28,000    -    -    -    -    (28,000)   -    -    -    - 
Series F Accrued Deemed Dividend   -    -    -    15,000    -    -    (15,000)   -    -    -    - 
Stock Issuance - Vesting Milestone   -    -    -    -    -    -    -    -    -    -    - 
Equity Compensation Charge   -    -    -    -    4,965    -    7,000    -    -    -    7,000 
Net Loss   -    -    -    -    -    -    -    (543,000)   -    -    (543,000)
                                                        
Balance June 30, 2026   130,000   $1,032,000    70,000   $555,000    2,613,670   $27,891,000   $7,676,000   $(29,270,000)   (4,426)  $(161,000)  $7,723,000 
                                                        
Series E Accrued Deemed Dividend   -    28,000    -    -    -    -    (28,000)   -    -    -    - 
Series F Accrued Deemed Dividend   -    -    -    15,000    -    -    (15,000)   -    -    -    - 
Stock Issuance - Vesting Milestone   -    -    -    -    -    -    -    -    -    -    - 
Equity Compensation Charge   -    -    -    -    -    -    7,000    -    -    -    7,000 
Incremental fair value upon modification of common stock warrants   -    -    -    -    -    -    27,000    -    -    -    27,000 
Net Loss   -    -    -    -    -    -    -    (866,000)   -    -    (866,000)
                                                        
Balance September 30, 2026   130,000   $1,060,000    70,000   $570,000    2,613,670   $27,891,000   $7,667,000   $(30,136,000)   (4,426)  $(161,000)  $6,891,000 

 

See accompanying notes to unaudited condensed consolidated financial statements.

Reflects a 1-for-10 reverse stock split on the Company’s common stock effective October 1, 2025

 

Yunhong Green CTI, Ltd

Unaudited Condensed Consolidated Statements of Shareholders’ Equity

 

   Series E Preferred Stock   Series F Preferred Stock   Common Stock   Paid-in   Accumulated (Deficit)  

Less

Treasury Stock

     
   Shares   Amount   Shares   Amount   Shares   Amount   Capital   Earnings   Shares   Amount   TOTAL 
                                             
Balance December 31, 2024   130,000   $864,000    70,000   $465,000    2,599,185   $27,533,000   $7,858,000   $(25,856,000)   (4,426)  $(161,000)  $10,703,000 
                                                        
Series E Accrued Deemed Dividend   -    28,000    -    -    -    -    (28,000)   -    -    -    - 
Series F Accrued Deemed Dividend   -    -    -    15,000    -    -    (15,000)   -    -    -    - 
Common Stock Issuance for Rent        -    -    -    27,604    182,000    -    -    -    -    182,000 
Equity Compensation Charge   -    -    -    -    -    -    9,000    -    -    -    9,000 
Net Loss   -    -    -    -    -    -    -    (416,000)   -    -    (416,000)
                                                        
Balance March 31, 2025   130,000   $892,000    70,000   $480,000    2,626,789   $27,715,000   $7,824,000   $(26,272,000)   (4,426)  $(161,000)  $10,478,000 
                                                        
Series E Accrued Deemed Dividend   -    28,000    -    -    -    -    (28,000)   -    -    -    - 
Series F Accrued Deemed Dividend   -    -    -    15,000    -    -    (15,000)   -    -    -    - 
Common Stock Issuance for Advance Investor Deposit        -    -    -    150,000    1,050,000    -    -    -    -    1,050,000 
Equity Compensation Charge   -    -    -    -    -    -    8,000    -    -    -    8,000 
Net Loss   -    -    -    -    -    -    -    (185,000)   -    -    (185,000)
                                                        
Balance June 30, 2025   130,000   $920,000    70,000   $495,000    2,776,789   $28,765,000   $7,789,000   $(26,457,000)   (4,426)  $(161,000)  $11,351,000 
                                                        
Series E Accrued Deemed Dividend   -    28,000    -    -    -    -    (28,000)   -    -    -    - 
Series F Accrued Deemed Dividend   -    -    -    15,000    -    -    (15,000)   -    -    -    - 
Equity Compensation Charge   -    -    -    -    -    -    1,000    -    -    -    1,000 
Net Loss   -    -    -    -    -    -    -    (811,000)   -    -    (811,000)
                                                        
Balance September 30, 2025   130,000   $948,000    70,000   $510,000    2,776,789   $28,765,000   $7,747,000   $(27,268,000)   (4,426)  $(161,000)  $10,541,000 

 

See accompanying notes to unaudited condensed consolidated financial statements.

Reflects a 1-for-10 reverse stock split on the Company’s common stock effective October 1, 2025

 

4
Table of Contents

 

Yunhong Green CTI Ltd.

Notes to Unaudited Condensed Consolidated Financial Statements

 

Note 1 - Basis of Presentation and Significant Accounting Policies

 

The accompanying unaudited condensed consolidated interim financial statements have been prepared and, in the opinion of management, contain all material adjustments (consisting of those of a normal recurring nature) considered necessary to present fairly the consolidated financial position and the consolidated statements of loss and consolidated cash flows for the periods presented in conformity with generally accepted accounting principles for interim consolidated financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X.

 

Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America. Operating results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2026. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2025, filed on March 23, 2026, which can be found on the Company’s website (www.ctiindustries.com) or www.sec.gov.

 

The financial information presented in these financial statements has been rounded to the nearest thousand dollars ($000), which is in accordance with our policy to simplify the presentation. The financial information is not presented in thousand-dollar increments.

 

All of the Company’s historical share and per share information related to issued and outstanding common stock, outstanding share based awards and warrants exercisable for common stock in these financial statements have been adjusted, on a retroactive basis, to reflect the 1-for-10 reverse stock split approved by the Company’s shareholders on August 22, 2025 and effective October 1, 2025.

 

Principles of consolidation and nature of operations:

 

Yunhong Green CTI Ltd., its wholly owned subsidiary Yunhong Technology Industry (Hubei) Co., Ltd., and its inactive subsidiary CTI Supply, Inc. (collectively, the “Company”) (i) design, manufacture and distribute metalized balloon products throughout the world, (ii) distribute purchased latex balloon products, and (iii) operate systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products.

 

The condensed consolidated financial statements include the accounts of Yunhong Green CTI Ltd., CTI Supply, Inc., and Yunhong Technology Industry (Hubei) Co., Ltd. All intercompany accounts and transactions have been eliminated in consolidation. See Note 2 to the consolidated financial statements included in Form 10-K for the fiscal year ended December 31, 2025.

 

Use of estimates:

 

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the amounts reported of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include recoverability and impairment of long-lived assets, valuation allowances for doubtful accounts, inventory valuation and valuation of deferred tax assets.

 

Segments:

 

The Company views its operations and manages its business as one segment, both in terms of geography and operations. All manufacturing occurs in the United States. Due to the single reportable segment, this financial information is presented on the Consolidated Statements of Income (Loss). There are no significant segment expenses reported to the chief operating decision maker (CODM), which is the Chief Executive Officer. The Company’s CODM regularly reviews financial information presented and does not evaluate the Company’s operating segment using asset or liability information. Instead, the CODM uses revenue, gross margin, and net income or loss to allocate operating and capital resources and assess performance by comparing actual results to historical results and previously forecasted financial information.

 

5
Table of Contents

 

Earnings per share:

 

Basic (loss) per share is computed by dividing net loss attributable to common shareholders by the weighted average number of shares of common stock outstanding during each period.

 

Diluted (loss) per share is computed by dividing the net loss attributable to common shareholders by the weighted average number of shares of common stock and equivalents (stock options and warrants), unless antidilutive, during each period. In periods for which there is a net loss, diluted loss per common share is equal to basic loss per common share, since the effect of including any common stock equivalents would be antidilutive.

 

For both September 30, 2026 and 2025, common shares to be issued upon the exercise of warrants aggregated 55,600. No options were outstanding for the three months and nine months ended September 30, 2026 and 2025. The number of shares included in the determination of earnings on a diluted basis for the three and nine months ended September 30, 2026 and 2025 were none, as doing so would have been antidilutive.

 

Revenue recognition:

 

Net sales include revenues from sales of products and shipping and handling charges, net of estimates for product returns. Revenue is measured at the amount of consideration the Company expects to receive in exchange for the transferred products. Revenue is recognized at the point in time when we transfer the promised products to the customer and the customer obtains control over the products. The Company recognizes revenue for shipping and handling charges at the time the goods are shipped to the customer, and the costs of outbound freight are included in cost of sales, as we have elected the practical expedient included in ASC 606.

 

The Company provides for product returns based on historical return rates. While we incur costs for sales commissions to our sales employees and outside agents, we recognize commission costs concurrent with the related revenue, as the amortization period is less than one year and we have elected the practical expedient included in ASC 606. We do not incur incremental costs to obtain contracts with our customers. Our product warranties are assurance-type warranties, which promise the customer that the products are as specified in the contract. Therefore, the product warranties are not a separate performance obligation and are accounted for as described herein. Sales taxes assessed by governmental authorities are accounted for on a net basis and are excluded from net sales.

 

Note 2 – Liquidity and Going Concern

 

The Company’s financial statements are prepared using accounting principles generally accepted in the United States (“U.S. GAAP”) applicable to a going concern, which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has a cumulative net loss from inception to September 30, 2026 of approximately $30.1 million. The accompanying financial statements for the three and nine months ended September 30, 2026 have been prepared assuming the Company will continue as a going concern. Existing cash resources and cash expected to be generated from operations are not expected to be sufficient to fund the Company’s anticipated operating requirements over the next twelve months without additional financing.

 

The ability of the Company to continue as a going concern is dependent on the Company having adequate capital to fund its operating plan and performance. Management’s plans to continue as a going concern include raising additional capital, including through a potential registered offering of equity securities, as well as borrowings, continuing to focus on attaining profitable operations, and exploring alternative funding sources on an as needed basis. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans. The supply chain challenges, inflationary pressures and tariffs have impacted on the Company’s business operations to some extent and is expected to continue to do so and these impacts may include reduced access to capital. The ability of the Company to continue as a going concern may be dependent upon its ability to successfully secure other sources of financing and attain profitable operations. There is substantial doubt about the ability of the Company to continue as a going concern for one year from the issuance of the accompanying consolidated financial statements. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

The Senior Facilities described in Note 3 mature on April 30, 2027, within one year after the date these financial statements are issued, and the Company’s ability to continue as a going concern also depends on renewing, extending or refinancing the Senior Facilities on or before that date.

 

The Company’s primary sources of liquidity have traditionally been comprised of cash and cash equivalents as well as availability under a Credit Agreement. The Credit Agreement with Line Financial, as most recently amended in September 2025, includes a revolving credit facility for up to $7 million and a term loan of $0.7 million, all supported by the majority of our assets. This Agreement was extended during September 2025, to mature April 30, 2027, under substantially similar terms.

 

6
Table of Contents

 

Note 3 - Debt

 

Senior Facilities

 

On September 30, 2021 (the “Closing Date”), the Company entered into a loan and security agreement (the “Agreement”) with Line Financial (the “Lender”), which provides for a senior secured financing consisting of a revolving credit facility (the “Revolving Credit Facility”) in an aggregate principal amount of up to $7 million, as amended (the “Maximum Revolver Amount”), subject to borrowing base provisions, and term loan facility (the “Term Loan Facility”) in an aggregate principal amount of $731,250 (“Term Loan Amount” and, together with the Revolving Credit Facility, the “Senior Facilities”). The Senior Facilities are secured by substantially all assets of the Company. The Company has remained in compliance with all material covenants since inception.

 

Borrowings under the Revolving Credit Facility bear interest at the prime rate + 7.82% (14.82% as of September 30, 2026), payable monthly in arrears. The Term Loan Facility bears interest at the prime rate + 1.45% (8.45% as of September 30, 2026) and is repaid in 48 monthly installments of approximately $15,000. The Company also pays collateral monitoring fees of 4.62% of the eligible accounts receivable, inventory, and equipment supporting both facilities.

 

Originally maturing September 30, 2023, the Senior Facilities were extended to April 30, 2027 pursuant to a Fifth Amendment executed on September 30, 2025, which also increased the revolving commitment from $6.0 million to $7.0 million and added a 0.75% renewal fee, payable in two equal installments in October 2025 and September 2026. A $12,500 commitment fee was also incurred.

 

On August 24, 2026, the Company entered into a Sixth Amendment to increase the seasonal overadvance limit from $250,000 to $300,000, effective August 28, 2026. The Sixth Amendment also required a one-time payment of $20,000. The seasonal overadvance limit will expire on December 31, 2026, and all outstanding overadvance amounts must be repaid in full by January 31, 2027.

 

The facility automatically renews for successive one-year periods unless either party provides written notice of termination not less than 90 days prior to the end of the then-current term. The Company may prepay the Term Loan Facility (together with accrued interest and any applicable prepayment fee) in whole, but not in part, upon at least 60 days’ prior written notice.

 

The Agreement requires the Company to maintain minimum tangible net worth of $4.0 million, subject to adjustment by the Lender. The Company was in compliance with this covenant as of September 30, 2026 and 2025. The Agreement also limits additional indebtedness, liens, dividends, mergers, and annual capital expenditures exceeding $1.0 million. As of September 30, 2026 and December 31, 2025, the term loan balance was approximately $0.41 and $0.5 million, respectively, and the revolving balance was $4.8 million and $6.8 million, respectively. There was $2.2 million remaining available for borrowing under the Revolving Credit Facility as of September 30, 2026.

 

Notes payable, Related Party

 

The Company is party to a note payable to John H. Schwan, former Director and former Chairman of the Board, for an initial amount of $1.3 million as of December 31, 2023 and an interest rate of 6%. The Company repaid $1 million to Mr. Schwan during January 2024. The parties agreed to the payment of the remaining $0.3 million at a future date to be determined. This related party note payable is subordinate to the Senior Facilities.

 

7
Table of Contents

 

Note 4 - Shareholders’ Equity

 

Series E Convertible Preferred Stock

 

The Company’s Articles of Incorporation, as amended, authorized the issuance of 130,000 shares of Series E Convertible Preferred Stock (“Series E Preferred”). Each share of Series E Preferred is convertible at the holder’s option into a number of shares of common stock equal to the sum of its $10 stated value and any declared and unpaid dividends, divided by the conversion price. The conversion price is the lower of the fixed price stated in the Certificate of Designation and the lowest daily volume-weighted average price of the common stock during the ten trading days before conversion. Holders of the Series E Preferred will be entitled to receive quarterly dividends at the annual rate of 8.5% of the stated value ($10 per share) and have a liquidation preference over common stock. Such dividends may be paid in cash or otherwise based on the terms of the agreement. Accrued dividends of $289,000 and $205,000 were recorded as of September 30, 2026 and December 31, 2025, respectively. In addition, warrants to purchase 36,140 shares of the Company’s common stock were issued with respect to this transaction and are equity classified instruments. These warrants are exercisable until March 2029, following the extension described below.

 

Series F Convertible Preferred Stock

 

The Company’s Articles of Incorporation, as amended, authorized the issuance of 70,000 shares of Series F Preferred. Each share of Series F Preferred is convertible at the holder’s option into a number of shares of common stock equal to the sum of its $10 stated value and any declared and unpaid dividends, divided by the conversion price. The conversion price is the lower of the fixed price stated in the Certificate of Designation and the lowest daily volume-weighted average price of the common stock during the ten trading days before conversion. Holders of the Series F Preferred will be entitled to receive quarterly dividends at the annual rate of 8.5% of the stated value ($10 per share) and have a liquidation preference over common stock. Such dividends may be paid in cash or stock, at the Company’s discretion, based on the terms of the agreement. Accrued dividends of $155,000 and $110,000 were recorded as of September 30, 2026 and December 31, 2025, respectively. In addition, warrants to purchase 19,460 shares of the Company’s common stock were issued with respect to this transaction and are equity classified instruments. These warrants are exercisable until March 2029, following the extension described below.

 

Each Certificate limits conversion so that the holder’s beneficial ownership does not exceed 4.99% of the outstanding common stock, which the holder may increase on 61 days’ prior notice, and, absent shareholder approval, limits the aggregate shares issuable on conversion of each series to 20% of the common stock outstanding immediately before the original issuance of that series.

 

Warrants

 

As described above, in connection with the Series E and F convertible preferred equity issuances, a total of 55,600 warrants were issued, exercisable for the Company’s common stock at the lower of $15.2 per share or the lowest daily VWAP of the Company’s common stock during the 10 trading days preceding exercise.

 

On September 29, 2026, in connection with a proposed public offering, the Company entered into a Conversion Restriction and Waiver Agreement with each of Wickbur Holdings LLC (Series E Preferred and Warrant E-1) and Agile Wisdom International Limited (Series F Preferred and Warrant F-1). Each holder agreed not to convert its preferred stock, exercise its warrant or transfer either security, other than to a permitted transferee bound by the agreement, during a restricted period. The restricted period ends 61 days after the holder gives written notice of termination, which may be given no earlier than the later of the final closing or abandonment of the offering and the second anniversary of the agreement. Each holder consented to the offering and waived its piggyback registration rights for the offering. The agreements conformed the securities purchase agreements’ conversion terms to the Certificates of Designation, and each holder released claims based on the former conversion terms. During the restricted period, the Company waived its right to require exercise of the warrants and agreed to suspend its option to pay Series F dividends in common stock. Dividends on both series continue to accrue at 8.5% per year. Cash payments are subject to applicable law and the restrictions under the Senior Facilities. In consideration of the holders’ commitments, the Company extended the warrant expirations from March 11, 2027 to March 11, 2029. The exercise price and the number of shares under the warrants did not change, and the warrants remain equity classified. The approximately $27,000 increase in the fair value of the warrants from the modification was recorded as a deferred offering cost, with a corresponding increase in additional paid-in capital. The deferred cost will be charged against the offering proceeds on completion or expensed if the offering is abandoned.

 

8
Table of Contents

 

A summary of the Company’s stock warrant activity is as follows:

 

   Shares under
Option (warrant)
   Weighted Average
Exercise Price
 
Balance at December 31, 2025   55,600   $15.20 
Granted   -    - 
Cancelled/Expired   -    - 
Exercised/Issued   -    - 
Outstanding at September 30, 2026   55,600    15.20 
           
Exercisable at September 30, 2026 (1)   -   $15.20 

 

(1)The warrants may not be exercised during the restricted period under the Conversion Restriction and Waiver Agreements described above. The exercise price shown is the fixed component; the exercise price is the lower of $15.20 per share and the lowest daily volume-weighted average price of the common stock during the ten trading days preceding exercise.

 

As of September 30, 2026 the Company was required under the Certificates of Designation to reserve the following shares of its authorized but unissued common stock for conversion of the preferred stock and exercise of the warrants:

 

2025 Common Stock Warrants   55,600 
Shares reserved for warrants as of September 30, 2026   55,600 

 

Security  Preferred Shares
Authorized/
Outstanding
   Conversion Price   Common Shares
Reserved
 
Series E Preferred Stock   130,000   $2.66    587,062 
Series F Preferred Stock   70,000   $2.66    316,110 
Shares reserved for Preferred Stock as of September 30, 2026             903,172 

 

The Certificates of Designation require the Company to reserve at least 120% of the shares issuable on conversion, determined without regard to the ownership and issuance limits. Because the conversion price varies with the market price of the common stock, the number of shares required to be reserved also varies.

 

Restricted Stock Awards

 

Restricted Stock Units, Performance-Based Restricted Stock Units and Restricted Stock Awards:

 

Aggregated information regarding RSUs, PSUs and RSAs granted under the Plan is summarized below:

 

   RSUs, PSUs & RSAs   Weighted
Average Grant-
Date Fair Value
 
Outstanding, unvested at December 31, 2025   20,158   $3.63 
Granted   -    - 
Vested   (9,404)  $6.47 
Forfeited   -    - 
Outstanding, unvested at September 30, 2026   10,754   $2.63 

 

Differences between the amount of vested awards and shares of common stock issued are attributable to timing differences.

 

Note 5 - Legal Proceedings

 

The Company may be party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, we do not believe any of these proceedings will have, individually or in the aggregate, a material adverse effect upon our financial condition, cash flows or future results of operation.

 

9
Table of Contents

 

Note 6 – Inventories

 

   September 30, 2026   December 31, 2025 
Raw materials  $1,190,000   $749,000 
Work in process   2,650,000    2,569,000 
Finished goods   4,300,000    5,420,000 
Total inventories  $8,140,000   $8,738,000 

 

Note 7 - Concentration of Credit Risk

 

Concentration of credit risk on trade accounts receivable is concentrated in a limited number of customers with higher sales volumes; the remaining receivables are spread across a large number of customers. The Company performs ongoing credit evaluations and provides an allowance for potential credit losses against the portion of accounts receivable which is estimated to be uncollectible. Such losses have historically been within management’s expectations.

 

During the three and nine months ended September 30, 2026 and 2025, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales. Sales to these customers for the three and nine months ended September 30, 2026 and 2025 are as follows:

 

   Three Months Ended   Three Months Ended 
   September 30, 2026   September 30, 2025 
Customer  Net Sales  

% of Net

Sales

   Net Sales  

% of Net

Sales

 
Customer A  $1,762,000    55%  $1,433,000    48%
Customer B  $930,000    29%  $723,000    24%

 

   Nine Months Ended   Nine Months Ended 
   September 30, 2026   September 30, 2025 
Customer  Net Sales  

% of Net

Sales

   Net Sales  

% of Net

Sales

 
Customer A  $5,945,000    44%  $6,678,000    50%
Customer B  $5,434,000    40%  $3,702,000    28%

 

As of September 30, 2026, the outstanding accounts receivable balance from these two customers was $3.1 million.

 

Note 8 - Related Party Transactions

 

Ms. Jana M. Schwan is the Company’s Chief Executive Officer. Her father, John H. Schwan, held several positions with the Company over many years, most recently as Chairman of the Board until June 2020 as discussed in Note 3, Mr. John H. Schwan was owed approximately $0.3 million as of both September 30, 2026 and December 31, 2025, in a note from the Company.

 

Icy Mellon LLC, the landlord of the Company’s Barrington Facility, is a shareholder of the Company. The Company’s Vice President – Strategy and Business Development also serves as a Manager of Icy Mellon LLC. On January 13, 2025, the Company issued 27,604 shares of common stock with an aggregate fair value of approximately $182,000 to settle rent payable that had been included in accrued expenses as of December 31, 2024. Rent expense related to the Barrington facility was approximately $145,000 and $141,000 for the three months ended September 30, 2026, and 2025, respectively. As of September 30, 2026 and December 31, 2025, amounts due to Icy Mellon LLC totaled approximately $428,000 and $234,000.

 

During the nine months ended September 30, 2026, the Company received a cash advance of $75,000 from Icy Mellon LLC. The Company had previously received cash advances totaling $150,000 from Icy Mellon LLC during 2025, resulting in aggregate advances of $225,000 held as of September 30, 2026. The advances were provided pending the execution of a definitive agreement, and the specific terms and purpose of the advances have not yet been finalized. Accordingly, the advances have been recorded as advances from investor on the Company’s condensed consolidated balance sheets.

 

Note 9 - Leases

 

We enter into lease contracts for certain of our facilities at two locations. Our leases have remaining lease terms of two and five years.

 

The weighted average discount rate for our operating leases is 14.05%. We calculated the weighted-average discount rate using incremental borrowing rates, which equal the rates of interest that we would pay to borrow funds on a fully collateralized basis over a similar term.

 

At September 30, 2026, maturities of operating lease liabilities are as follows:

 

      
2026  $264,000 
2027   1,083,000 
2028   1,119,000 
2029   627,000 
2030   646,000 
Thereafter   217,000 
Total Lease Payments   3,956,000 
Less: Imputed interest   (924,000)
Total Lease Liabilities  $3,032,000 

 

10
Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Cautionary Note Regarding Forward Looking Statements

 

This Quarterly Report on Form 10-Q includes both historical and “forward-looking statements” within the meaning of federal securities law. All such statements are qualified by this cautionary note, which is provided pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future results. Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this Quarterly Report on Form 10-Q. We disclaim any intent or obligation to update any forward-looking statements after the date of this Quarterly Report on Form 10-Q to conform such statements to actual results or to changes in our opinions or expectations. These forward-looking statements are affected by factors, risks, uncertainties and assumptions that we make, including, without limitation, those discussed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 under the heading “Risk Factors.”

 

Overview

 

We produce film products for novelty, packaging and container applications. These products include foil balloons, latex balloons and related products, films for packaging and custom product applications, and flexible containers for packaging and consumer storage applications. We produce all of our film products for packaging, container applications and most of our foil balloons at our plant in Lake Barrington, Illinois. The Company purchases latex balloons from an unrelated vendor and distributes in the United States, particularly to those customers that prefer a combined solution for foil and latex balloons. Substantially all our film products for packaging and custom product applications are sold to customers in the United States. We market and sell our novelty items, Balloon inspired gifts (balloons and candy arranged to look like a flower bouquet for gifting) and flexible containers for consumer use primarily in the United States. The Company incorporated “Green” into the Company name to communicate our intention to supply biodegradable and compostable materials to the marketplace that are developed by our partners in Asia. We created a new subsidiary, in part, for this purpose. In recent periods, the U.S. government has imposed tariffs on certain goods imported from countries including China. Existing and future trade tariffs, import duties and quotas could also materially increase our costs of procuring the materials we use and disrupt the markets for the products we handle, which in turn could have a material adverse effect on our financial position, results of operations and cash flows.

 

Senior Credit Facilities

 

As of September 30, 2026, the Company maintained senior secured credit facilities with Line Financial, consisting of a $7.0 million revolving credit facility and a $0.7 million term loan. The facilities are secured by substantially all Company assets.

 

Borrowings under the Revolving Credit Facility bear interest at the prime rate + 7.82% (14.82% as of September 30, 2026) while the term loan bears interest at the prime rate plus 1.45% and is repaid in monthly installments of approximately $15,000. The facilities include standard financial and operational covenants, including a minimum tangible net worth requirement of $4.0 million, with which the Company was in compliance as of September 30, 2026.

 

In September 2025, the Company executed a Fifth Amendment extending maturity to April 30, 2027, and increasing the revolving commitment from $6.0 million to $7.0 million. The amendment also introduced a 0.75% renewal fee payable in two equal installments (October 2025 and September 2026) and a $12,500 commitment fee associated with the expanded facility.

 

On August 24, 2026, the Company entered into a Sixth Amendment to increase the seasonal overadvance limit from $250,000 to $300,000, effective August 28, 2026. The Sixth Amendment also required a one-time payment of $20,000. The seasonal overadvance limit will expire on December 31, 2026, and all outstanding overadvance amounts must be repaid in full by January 31, 2027. Except as described above, all other material terms, including borrowing base, collateral, and covenants, remained unchanged.

 

At September 30, 2026, the company had $4.8 million outstanding on the revolving facility and $0.4 million on the term loan, with $2.2 million of remaining borrowing capacity.

 

Note Payable, Related Party

 

The Company also has a subordinated note payable to former Director and former Chairman John H. Schwan bearing 6% interest, with a balance of $0.3 million remaining after a $1.0 million repayment in January 2024.

 

11
Table of Contents

 

Results of Operations

 

Net Sales: Net sales for the three-month periods ended September 30, 2026 and 2025 were approximately $3,127,000 and $2,953,000, respectively, representing an increase of $174,000 or 6% quarter-over-quarter. The increase is primarily attributable to the timing of sales. In addition, foil balloon volumes have increased during quarter-over-quarter, however, overall for the nine month period it reduced by 10% as one of our mass retail customers adjusted its replenishment practices beginning in the second half of 2025, which affected the three- and nine-month periods.

 

For the three-month period ended September 30, 2026 and 2025, net sales by product category were as follows:

 

   Three Months Ended         
   September 30, 2026   September 30, 2025         
Product Category 

$

(000) Omitted

  

% of

Net Sales

  

$

(000) Omitted

  

% of

Net Sales

   Variance  

%

change

 
                         
Foil Balloons  $2,520    81%  $2,352    80%  $168    7%
                               
Film Products   69    2%   253    8%   (184)   -73%
                               
Other   538    17%   348    12%   190    55%
                               
Total  $3,127    100%  $2,953    100%  $174    6%

 

For the nine-month periods ended September 30, 2026 and 2025, net sales were $13,180,000 and $13,212,000 respectively, representing a decrease of $32,000, or 0%.

 

For the nine-month periods ended September 30, 2026 and 2025, net sales by product category were as follows:

 

   Nine Months Ended         
   September 30, 2026   September 30, 2025         
Product Category 

$

(000) Omitted

  

% of

Net Sales

  

$

(000) Omitted

  

% of

Net Sales

   Variance  

%

change

 
                         
Foil Balloons  $8,624    66%  $9,597    73%  $(973)   -10%
                               
Film Products   317    2%   1,030    8%   (713)   -69%
                               
Other   4,239    32%   2,585    19%   1,654    64%
                               
Total  $13,180    100%  $13,212    100%  $(32)   0%

 

12
Table of Contents

 

Foil Balloons. Revenues from the sale of foil balloons increased during the three-month period ended September 30, 2026 to $2,520,000 compared to $2,352,000 during the same period of 2025. The increase is related to the timing of orders and shipments.

 

Revenues from the sale of foil balloons decreased during the nine-month period ended September 30, 2026 to $8,624,000 compared to $9,597,000 during the same period of 2025. The decrease is related to the timing of orders and shipments. In the second half of 2025 one of our large mass retail customers made some adjustments to their replenishment system due to a surplus in their supply chain.

 

Films. Revenues from the sale of commercial films were $69,000 and $317,000 during the three and nine month periods ended September 30, 2026, compared to $253,000 and $1,030,000 during the same periods of 2025. Sales in this area have been inconsistent due to a small number of customers and a significant number of competitors. Generally, our customers have experienced lower sales in this area compared to previous years, which has negatively impacted our sales, and we are uncertain whether demand in this segment will recover.

 

Other Revenues: Revenues from the sale of other products were $537,000 and $4,239,000 during the three and nine month periods ended September 30, 2026 compared to $348,000 and $2,585,000 during the same periods of 2025. Other revenues during these periods primarily consisted of: (i) sales of balloon-inspired gift products, including candy and small inflated balloons packaged in small containers; and (ii) sales of accessories and supply items related to balloon products. The increase in other revenues was primarily attributable to the timing of Valentine’s Day-related shipments, as a greater portion of shipments associated with the 2025 Valentine’s Day season occurred in December 2024, resulting in lower other revenues during 2025.

 

Sales to a limited number of customers continue to represent a large percentage of our net sales. The table below illustrates the impact on sales of our top three and ten customers for the three and nine month periods ended September 30, 2026 and 2025.

 

   Three Months Ended September 30, 
   % of Sales 
   2026   2025 
         
Top 3 Customers   87%   78%
           
Top 10 Customers   94%   92%

 

   Nine Months Ended September 30, 
   % of Sales 
   2026   2025 
         
Top 3 Customers   87%   82%
           
Top 10 Customers   94%   93%

 

13
Table of Contents

 

During the three and nine months ended September 30, 2026 and 2025, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales. Sales to these customers for the three and nine months ended September 30, 2026 and 2025 are as follows:

 

   Three Months Ended September 30, 
   2026   2025 
Customer  Net Sales   % of Net Sales   Net Sales   % of Net Sales 
Customer A  $1,762,000    55%  $1,433,000    48%
Customer B  $930,000    29%  $723,000    24%

 

   Nine Months Ended September 30, 
   2026   2025 
Customer  Net Sales   % of Net Sales   Net Sales   % of Net Sales 
Customer A  $5,945,000    44%  $6,678,000    50%
Customer B  $5,434,000    40%  $3,702,000    28%

 

As of September 30, 2026, the total amounts owed to the Company by these customers were approximately $3,101,000 or 99% of the Company’s consolidated gross accounts receivable. The amounts owed at September 30, 2025 by these customers were $2,595,000 or 93% of the Company’s consolidated accounts receivable. This concentration also affects the Company’s liquidity: eligible accounts receivable from these customers constitute a substantial portion of the borrowing base under the Revolving Credit Facility, and the loss of, or significant payment delays by, either customer would reduce availability thereunder.

 

Cost of Sales. During the three and nine month periods ended September 30, 2026, the cost of sales was $2,796,000 and $11,296,000 compared to $2,886,000 and $11,301,000 respectively for the same periods of 2025, with the change driven largely by changes in sales volume. As a percentage of sales, cost of sales was 89% and 86% during the three and nine months ended September 30, 2026, compared to 98% and 86% during the three and nine months ended September 30, 2025. The decrease in cost of sales during the three months ended September 30, 2026 is attributed to product mix that provides better margins.

 

General and Administrative. During the three and nine month periods ended September 30, 2026, general and administrative expenses were $868,000 and $2,466,000 as compared to $869,000 and $2,462,000, respectively, for the same periods of 2025.

 

Selling, Advertising and Marketing: During the three and nine month periods ended September 30, 2026, selling, advertising and marketing expenses were $153,000 and $525,000 as compared to $181,000 and $591,000, respectively, for the same period in 2025. Selling, advertising and marketing costs have decreased by $28,000 and $66,000.

 

Other Income (Expense): During the three and nine month periods ended September 30, 2026, the Company incurred interest expense of $183,000 and $650,000 as compared to interest expense of $198,000 and $662,000, respectively, during the same periods of 2025.

 

Financial Condition, Liquidity and Capital Resources

 

Cash Flow Items.

 

Operating Activities. During the nine months ended September 30, 2026, net cash provided by operations was $2,240,000, compared to net cash provided by operations during the nine months ended September 30, 2025 of $2,300,000.

 

Significant changes in working capital items during the nine months ended September 30, 2026 included:

 

  ● A decrease in accounts receivable of $2,878,000 compared to a decrease in accounts receivable of $2,712,000 in the same period of 2025.
     
  ● A decrease in inventory of $598,000 compared to an increase in inventory of $187,000 in 2025.
     
  ● An increase in trade payables of $142,000 compared to an increase in trade payables of $212,000 in 2025.
     
  ● A decrease in prepaid expenses and other assets of $71,000 compared to a decrease of $228,000 in 2025.
     
  ●

A decrease in accrued liabilities of $286,000 compared to an increase in accrued liabilities of $94,000 in 2025.

 

  ● An increase in advance investor deposits of $75,000 compared to an increase of $100,000 in 2025.

 

Investing Activity. During the nine months ended September 30, 2026, cash used in investing activity was $106,000, compared to cash used in investing activity for the same period of 2025 in the amount of $68,000.

 

Financing Activities. During the nine months ended September 30, 2026, cash used in financing activities was $2,120,000 compared to cash used in financing activities for the same period of 2025 in the amount of $2,065,000. Financing activity during 2026 consisted principally of changes in the balances of revolving and principal repayments on term loan debt.

 

Liquidity and Capital Resources.

 

At September 30, 2026, the Company had cash balances of $111,000 compared to cash balances of $387,000 for the same period of 2025.

 

14
Table of Contents

 

The ability of the Company to continue as a going concern is dependent on the Company executing its business plan and, if unable to do so, in obtaining adequate capital on acceptable terms to fund any operating losses. Management’s plans to continue as a going concern include raising additional capital, including through a potential registered offering of equity securities, as well as borrowings, continuing to focus on attaining profitable operations, and exploring alternative funding sources on an as needed basis. However, management cannot provide any assurances that the Company will be successful in accomplishing any of its plans.

 

The supply chain constraints, inflationary pressures and tariffs are expected to impact to some extent our operations and reduced access to capital. The ability of the Company to continue as a going concern is dependent upon its ability to successfully generate or otherwise secure other sources of financing and attain profitable operations. There is substantial doubt about the ability of the Company to continue as a going concern for one year from the issuance of the accompanying consolidated financial statements. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Although the Company remained in compliance with all financial covenants under the Credit Agreement as of September 30, 2026, management concluded that substantial doubt exists because anticipated operating cash flows and liquidity remain dependent upon obtaining additional financing or achieving sustained profitability.

 

The Company’s primary sources of liquidity have traditionally been comprised of cash and cash equivalents as well as availability under the Credit Agreement. The Senior Facilities mature on April 30, 2027. There can be no assurance that the Company will be able to renew, extend or refinance the Senior Facilities, or obtain additional financing, on acceptable terms or at all.

 

Seasonality

 

In the foil balloon product line, sales have historically been seasonal with approximately 40% occurring in the period from December through March of the succeeding year and 24% being generated in the period July through October in recent years.

 

Critical Accounting Estimates

 

The critical accounting estimates utilized by the Company in preparation of the accompanying financial statements are set forth in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations”. There have been no material changes to these policies since December 31, 2025.

 

Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

(a) Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed in the reports filed or submitted under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified by the Commission’s rules and forms. Disclosure controls and procedures include controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act are properly recorded, processed, summarized and reported within the time periods required by the Commission’s rules and forms.

 

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Corporate Controller (principal financial officer), of the effectiveness of the design and operation of these disclosure controls and procedures, as such term is defined in Exchange Act Rule 13a-15(e), as of September 30, 2026. Based on this evaluation, the Chief Executive Officer (principal executive officer) and Corporate Controller (principal financial officer) concluded that our disclosure controls and procedures were not effective as of September 30, 2026, the end of the period covered by this Quarterly Report on Form 10-Q, due to the material weaknesses described below.

 

15
Table of Contents

 

(b) Management’s Report on Internal Control over Financial Reporting

 

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act.

 

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness of internal control over financial reporting to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management has assessed the effectiveness of our internal control over financial reporting as of September 30, 2026. In making our assessment of the effectiveness of internal control over financial reporting, management used the criteria set forth in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”).

 

A material weakness is a control deficiency, or combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the registrant’s annual or interim financial statements will not be prevented or detected on a timely basis. As a result of our evaluation of our internal control over financial reporting, management identified the following material weaknesses in our internal control over financial reporting:

 

  ● We lack a sufficient number of accounting professionals with the necessary knowledge, experience and training to adequately account for the application of new accounting standards as well as significant, unusual transactions particularly with regard to equity financing arrangements and the timing of recognition of certain non-cash charges.

 

Accordingly, management concluded that we did not maintain effective internal control over financial reporting as of September 30, 2026.

 

Plan for Remediation of Material Weakness

 

The Company intends to remediate the material weakness through measures that are expected to include engaging outside technical accounting resources with respect to significant and unusual transactions, including equity financing arrangements; enhancing management review procedures over the application of new accounting standards and the timing of recognition of non-cash charges; and periodic reporting to the Audit Committee on remediation progress. As management continues to evaluate and refine our internal control framework, additional steps may be taken to address any remaining deficiencies or to further strengthen remediation measures already in place.

 

(c) Changes in Internal Control over Financial Reporting

 

Based on the evaluation described above, and to the best of management’s knowledge, we did not identify any changes in our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that we believe have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

16
Table of Contents

 

Part II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

The Company may be party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, we do not believe any of these proceedings will have, individually or in the aggregate, a material adverse effect upon our financial condition, cash flows or future results of operation.

 

Item 1A. Risk Factors

 

The following supplements the risk factors in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025. Our Series E and Series F preferred stock and related warrants could dilute our common shareholders. The conversion price of our Series E and Series F preferred stock varies with the market price of our common stock and has no stated minimum. A decline in our common stock price could increase the number of shares issuable on conversion, subject to the ownership and issuance limits in the Certificates of Designation. Under the September 29, 2026 agreements described in Note 4, the holders may not convert their preferred stock or exercise the related warrants during the restricted period, which ends 61 days after a holder gives notice following the later of the second anniversary of its agreement and the final closing or abandonment of our proposed offering. Once the restrictions end, shares issued on conversion or exercise could reduce existing shareholders’ ownership and voting percentages, and sales of those shares could put downward pressure on our stock price.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

On September 29, 2026, the Company amended Warrants E-1 and F-1, held by Wickbur Holdings LLC and Agile Wisdom International Limited and covering 36,140 and 19,460 shares of common stock, respectively, to extend their expiration date from March 11, 2027 to March 11, 2029. The exercise price and number of shares were not changed. The amendments were made in consideration of the holders’ agreements described in Note 4 to the condensed consolidated financial statements. No cash consideration was received, and no commission or other remuneration was paid. The Company relied on the exemption from registration in Section 4(a)(2) of the Securities Act of 1933 for a transaction with two existing holders, each an accredited investor, without general solicitation. The Company did not repurchase any of its equity securities during the quarter.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

17
Table of Contents

 

Item 6. Exhibits

 

The following are being filed as exhibits to this report:

 

Exhibit

Number

  Description
     
4.1*   Amendment to Warrant No. E-1, dated September 29, 2026, between Yunhong Green CTI Ltd. and Wickbur Holdings LLC (included as Exhibit C to Exhibit 10.1).
4.2*   Amendment to Warrant No. F-1, dated September 29, 2026, between Yunhong Green CTI Ltd. And Agile Wisdom International Limited (included as Exhibit C to Exhibit 10.2).
10.1*   Conversion Restriction and Waiver Agreement, dated September 29, 2026, between Yunhong Green CTI Ltd. and Wickbur Holdings LLC
10.2*   Conversion Restriction and Waiver Agreement, dated September 29, 2026, between Yunhong Green CTI Ltd, and Agile Wisdom International Limited
10.3*   Sixth Amendment to Loan and Security Agreement, dated August 24, 2026, between Yunhong Green CTI Ltd. And Line Financial
31.1*   Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
31.2*   Certification of Corporate Controller and Principal Financial Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
32**   Certification of Chief Executive Officer, Corporate Controller and Principal Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).
101*   Interactive Data Files, including the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, formatted in inline XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income (Loss), (iii) the Consolidated Statements of Cash Flows, (iv) Consolidated Statements of Shareholders’ Equity, and (v) the Notes to Consolidated Financial Statements.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
     
*   Filed herewith
**   furnished herewith

 

18
Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 13, 2026 Yunhong Green CTI Ltd.
   
  By: /s/ Jana M. Schwan
    Jana M. Schwan
    Chief Executive Officer
     
  By: /s/ Sree Kommana
    Sree Kommana
    Corporate Controller and Principal Financial Officer

 

19

 

Keep reading